Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Prevalence of comorbidities in patients with primary SS or RA and in age- and sex-matched healthy individuals

From: Subclinical atherosclerosis and impaired bone health in patients with primary Sjogren’s syndrome: prevalence, clinical and laboratory associations

  SS (n = 64) RA (n = 77) HC (n = 60) P -value* P -value** P -value***
Arterial wall thickening (IMT >0.90 mm), % 59.4 63.8a 40.4 ns <0.05 <0.01
IMT levels, mean ± SD 1.0 ± 0.3 1.0 ± 0.4a 0.9 ± 0.2 ns <0.05 <0.01
Presence of plaque, % 68.8 84.4 56.9 <0.05 ns <0.001
Osteopenia, % 51.6 54.2a 36.8 ns ns ns
Osteoporosis, % 7.8 18.1a 14.0 ns ns ns
Osteoporosis/osteopenia, % 59.4 72.2a 50.9 ns ns <0.05
Fractures, % 12.5 23.9a 8.5 ns ns <0.05
  1. *Primary Sjogren's syndrome (SS) versus rheumatoid arthritis (RA); ** primary SS versus healthy controls (HC); *** RA versus HC; aanalysis based on 72 patients with RA. IMT, intima media thickness; ns, not significant.